Omega Therapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
SCHEDULE 13D/A: Omega Therapeutics to File for Chapter 11 Bankruptcy, Pursue Asset Sale with Flagship Pioneering Financing
Omega Therapeutics, Inc. has entered into a Restructuring Support Agreement with Flagship Pioneering affiliates, signaling an imminent Chapter 11 bankruptcy filing, a sale of substantially all assets, and securing debtor-in-possession financing.